Rhenman & Partners Asset Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-300,000
| Closed | -$951K | – | 86 |
|
|
2023
Q3 | $951K | Hold |
300,000
| – | – | 0.1% | 82 |
|
|
2023
Q2 | $1.49M | Hold |
300,000
| – | – | 0.16% | 78 |
|
|
2023
Q1 | $1.49M | Sell |
300,000
-40,000
| -12% | -$199K | 0.16% | 81 |
|
|
2022
Q4 | $2.14M | Hold |
340,000
| – | – | 0.22% | 81 |
|
|
2022
Q3 | $3.5M | Sell |
340,000
-10,000
| -3% | -$103K | 0.37% | 73 |
|
|
2022
Q2 | $3.99M | Buy |
+350,000
| New | +$3.99M | 0.45% | 60 |
|